Skip to main content
Top
Published in: Journal of Materials Science 4/2018

31-10-2017 | Chemical routes to materials

Designing and monitoring microstructural properties of oligosaccharide/co-solvent ternary complex particles to improve benznidazole dissolution

Authors: Polyanne N. de Melo, Lilia B. de Caland, Matheus F. Fernandes-Pedrosa, Arnóbio Antônio da Silva-Júnior

Published in: Journal of Materials Science | Issue 4/2018

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Benznidazole (BNZ) is the main drug used for the treatment of Chagas disease. However, its low aqueous solubility limits its efficacy. In this study, we have prepared host–guest inclusion complexes of BNZ with beta-cyclodextrin (β-CD) in solid phase and assessed the influence of the co-solvents triethanolamine (TEA) and 1-methyl-2-pyrrolidone (NMP) for improving the drug dissolution performance. The physicochemical properties of prepared spray-dried (SD) particles and physical mixtures (PM) were carefully monitored using FTIR, XRD and SEM images. The used co-solvents affected β-CD–drug interactions, the structural properties and drug dissolution behavior of particles. TEA did not improve the solubilizing effect of β-CD, while NMP was able to enhance drug dissolution performance in both SD and PM complexes. These promising results support the use of specific co-solvents with CD as a new raw material for insoluble compounds. The studied solid dispersions showed promising features to improve BNZ efficacy against Chagas disease.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
1.
2.
go back to reference Saini S, Quinot D, Lavoine N, Belgacem MN, Bras J (2017) β-Cyclodextrin-grafted TEMPO-oxidized cellulose nanofibers for sustained release of essential oil. J Mater Sci 52:3849–3861. doi:10.1007/s10853-016-0644-7 CrossRef Saini S, Quinot D, Lavoine N, Belgacem MN, Bras J (2017) β-Cyclodextrin-grafted TEMPO-oxidized cellulose nanofibers for sustained release of essential oil. J Mater Sci 52:3849–3861. doi:10.​1007/​s10853-016-0644-7 CrossRef
3.
go back to reference Vartiainen V, Bimbo LM, Hirvonen J, Kauppinen EI, Raula J (2017) Aerosolization, drug permeation and cellular interaction of dry powder pulmonary formulations of corticosteroids with hydroxypropyl-β-cyclodextrin as a solubilizer. Pharm Res 34:25–35CrossRef Vartiainen V, Bimbo LM, Hirvonen J, Kauppinen EI, Raula J (2017) Aerosolization, drug permeation and cellular interaction of dry powder pulmonary formulations of corticosteroids with hydroxypropyl-β-cyclodextrin as a solubilizer. Pharm Res 34:25–35CrossRef
4.
go back to reference Anandam S, Selvamuthukumar S (2014) Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects. J Mater Sci 49:8140–8153. doi:10.1007/s10853-014-8523-6 CrossRef Anandam S, Selvamuthukumar S (2014) Fabrication of cyclodextrin nanosponges for quercetin delivery: physicochemical characterization, photostability, and antioxidant effects. J Mater Sci 49:8140–8153. doi:10.​1007/​s10853-014-8523-6 CrossRef
5.
go back to reference Lopedota A, Cutrignelli A, Laquintana V, Denora N, Iacobazzi RM, Perrone M, Fanizza E, Mastrodonato M, Mentino D, Lopalco A, Depalo N, Franco M (2016) Spray dried chitosan microparticles for intravesical delivery of celecoxib: preparation and characterization. Pharm Res 33:2195–2208CrossRef Lopedota A, Cutrignelli A, Laquintana V, Denora N, Iacobazzi RM, Perrone M, Fanizza E, Mastrodonato M, Mentino D, Lopalco A, Depalo N, Franco M (2016) Spray dried chitosan microparticles for intravesical delivery of celecoxib: preparation and characterization. Pharm Res 33:2195–2208CrossRef
6.
go back to reference Loftsson T, Brewster ME (2012) Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci 101:3019–3032CrossRef Loftsson T, Brewster ME (2012) Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci 101:3019–3032CrossRef
7.
go back to reference Medarevíc D, Kachrimanis K, Djuríc Z, Ibríc S (2015) Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 78:273–285CrossRef Medarevíc D, Kachrimanis K, Djuríc Z, Ibríc S (2015) Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 78:273–285CrossRef
8.
go back to reference Vieira ACC, Fontes DAF, Chaves LL, Alves LDS, Freitas Neto JL, Soares JL, Soares-Sobrinho MFLR, Rolim LA, Rolim-Neto PJ (2015) Multicomponent systems with cyclodextrins and hydrophilic polymers for the delivery of Efavirenz. Carbohyd Polym 130:133–140CrossRef Vieira ACC, Fontes DAF, Chaves LL, Alves LDS, Freitas Neto JL, Soares JL, Soares-Sobrinho MFLR, Rolim LA, Rolim-Neto PJ (2015) Multicomponent systems with cyclodextrins and hydrophilic polymers for the delivery of Efavirenz. Carbohyd Polym 130:133–140CrossRef
9.
go back to reference Chibunova ES, Kumeev RS, Terekhova IV (2015) Thermodynamic study on salt effects on complex formation of α-, β- and γ-cyclodextrins with p-aminobenzoic acid. J Chem Thermodyn 91:30–34CrossRef Chibunova ES, Kumeev RS, Terekhova IV (2015) Thermodynamic study on salt effects on complex formation of α-, β- and γ-cyclodextrins with p-aminobenzoic acid. J Chem Thermodyn 91:30–34CrossRef
10.
go back to reference Terekhova I, Chibunova E, Kumeev R, Kruchinin S, Fedotova M, Kozbiał M, Wszelaka-Rylik M, Gierycz P (2015) Specific and nonspecific effects of biologically active inorganic salts on inclusion complex formation of cyclodextrins with aromatic carboxylic acids. Chem Eng Sci 122:97–103CrossRef Terekhova I, Chibunova E, Kumeev R, Kruchinin S, Fedotova M, Kozbiał M, Wszelaka-Rylik M, Gierycz P (2015) Specific and nonspecific effects of biologically active inorganic salts on inclusion complex formation of cyclodextrins with aromatic carboxylic acids. Chem Eng Sci 122:97–103CrossRef
11.
go back to reference Aiassa V, Zoppi A, Albesa I, Longhi MR (2015) Inclusion complexes of chloramphenicol with β-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production. Carbohyd Polym 121:320–327CrossRef Aiassa V, Zoppi A, Albesa I, Longhi MR (2015) Inclusion complexes of chloramphenicol with β-cyclodextrin and aminoacids as a way to increase drug solubility and modulate ROS production. Carbohyd Polym 121:320–327CrossRef
12.
go back to reference Banchero M, Manna L (2012) The use of lysine to enhance the supercritical complexation of ketoprofen and cyclodextrins. J Supercrit Fluid 67:76–83CrossRef Banchero M, Manna L (2012) The use of lysine to enhance the supercritical complexation of ketoprofen and cyclodextrins. J Supercrit Fluid 67:76–83CrossRef
13.
go back to reference Higashi K, Ideura S, Limwikrant W, Moribe K, Yamamoto K (2010) Simultaneous dissolution of naproxen and flurbiprofen from a novel ternary γ-cyclodextrin complex. Chem Pharm Bull 58:769–772CrossRef Higashi K, Ideura S, Limwikrant W, Moribe K, Yamamoto K (2010) Simultaneous dissolution of naproxen and flurbiprofen from a novel ternary γ-cyclodextrin complex. Chem Pharm Bull 58:769–772CrossRef
14.
go back to reference Gamer AO, Rossbacher R, Kaufmann W, Ravenzwaay B (2008) The inhalation toxicity of di- and triethanolamine upon repeated exposure. Food Chem Toxicol 46:2173–2183CrossRef Gamer AO, Rossbacher R, Kaufmann W, Ravenzwaay B (2008) The inhalation toxicity of di- and triethanolamine upon repeated exposure. Food Chem Toxicol 46:2173–2183CrossRef
15.
go back to reference Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients, 6th edn. Pharmaceutical Press, London, pp 601–755 Rowe RC, Sheskey PJ, Quinn ME (2009) Handbook of pharmaceutical excipients, 6th edn. Pharmaceutical Press, London, pp 601–755
16.
go back to reference Granero G, Garnero C, Longhi M (2003) The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 20:285–293CrossRef Granero G, Garnero C, Longhi M (2003) The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 20:285–293CrossRef
17.
go back to reference Mora MJ, Tártara LI, Onnainty R, Palma SD, Longhi MR, Granero GE (2013) Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes. Carbohyd Polym 98:380–390CrossRef Mora MJ, Tártara LI, Onnainty R, Palma SD, Longhi MR, Granero GE (2013) Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes. Carbohyd Polym 98:380–390CrossRef
18.
go back to reference Garnero C, Longhi M (2007) Study of ascorbic acid interaction with hydroxypropyl-β-cyclodextrin and triethanolamine, separately and in combination. J Pharmaceut Biomed 45:536–545CrossRef Garnero C, Longhi M (2007) Study of ascorbic acid interaction with hydroxypropyl-β-cyclodextrin and triethanolamine, separately and in combination. J Pharmaceut Biomed 45:536–545CrossRef
19.
go back to reference Miyako Y, Khalef N, Matsuzaki K, Pinal R (2010) Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. Int J Pharm 393:48–54CrossRef Miyako Y, Khalef N, Matsuzaki K, Pinal R (2010) Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. Int J Pharm 393:48–54CrossRef
20.
go back to reference Jain P, Yalkowsky SH (2007) Solubilization of poorly soluble compounds using 2-pyrrolidone. Int J Pharm 342:1–5CrossRef Jain P, Yalkowsky SH (2007) Solubilization of poorly soluble compounds using 2-pyrrolidone. Int J Pharm 342:1–5CrossRef
21.
go back to reference Medeiros ASA, Zoppi A, Barbosa EG, Oliveira JIN, Fernandes-Pedrosa MF, Longhi MR, Silva-Júnior AA (2016) Supramolecular aggregates of oligosaccharides with co-solvents in ternary systems for the solubilizing approach of triamcinolone. Carbohyd Polym 20:1040–1051CrossRef Medeiros ASA, Zoppi A, Barbosa EG, Oliveira JIN, Fernandes-Pedrosa MF, Longhi MR, Silva-Júnior AA (2016) Supramolecular aggregates of oligosaccharides with co-solvents in ternary systems for the solubilizing approach of triamcinolone. Carbohyd Polym 20:1040–1051CrossRef
22.
go back to reference Dias LC, Dessoy MA (2009) Quimioterapia da doença de chagas: estado da arte e perspectivas no desenvolvimento de novos fármacos (Chemotherapy of Chagas’ disease: state of the art and perspectives for the development of new drugs), Quim. Nova 32:2444–2457 (in Portuguese) Dias LC, Dessoy MA (2009) Quimioterapia da doença de chagas: estado da arte e perspectivas no desenvolvimento de novos fármacos (Chemotherapy of Chagas’ disease: state of the art and perspectives for the development of new drugs), Quim. Nova 32:2444–2457 (in Portuguese)
23.
go back to reference Hall BS, Wilkinson SR (2012) Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation. Antimicrob Agents Chemother 56:115–123CrossRef Hall BS, Wilkinson SR (2012) Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation. Antimicrob Agents Chemother 56:115–123CrossRef
24.
go back to reference Maximiano FP, Costa GHY, Souza J, Cunha-Filho MSS (2010) Physicochemical characterization of antichagasic benznidazole, Quim. Nova 33:1714–1719 (in Portuguese) Maximiano FP, Costa GHY, Souza J, Cunha-Filho MSS (2010) Physicochemical characterization of antichagasic benznidazole, Quim. Nova 33:1714–1719 (in Portuguese)
26.
go back to reference Salomon CJ (2012) First century of Chagas’ disease: an overview on novel approaches to nifurtimox and benznidazole delivery systems. J Pharm Sci 101:888–894CrossRef Salomon CJ (2012) First century of Chagas’ disease: an overview on novel approaches to nifurtimox and benznidazole delivery systems. J Pharm Sci 101:888–894CrossRef
27.
go back to reference Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Arment IA (2009) Side effects of benznidazole as treatment in chronic Chagas’ disease: fears and realities. Expert Rev Anti Infect Ther 7:157–163CrossRef Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, Bertocchi G, Arment IA (2009) Side effects of benznidazole as treatment in chronic Chagas’ disease: fears and realities. Expert Rev Anti Infect Ther 7:157–163CrossRef
28.
go back to reference Paula FR, Jorge SD, Almeida LV, Pasqualoto KFM, Tavares LC (2009) Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents. Bioorgan Med Chem 17:2673–2679CrossRef Paula FR, Jorge SD, Almeida LV, Pasqualoto KFM, Tavares LC (2009) Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents. Bioorgan Med Chem 17:2673–2679CrossRef
29.
go back to reference Bernardes LSC, Zani CL, Carvalho I (2013) Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Curr Med Chem 20:2673–2696CrossRef Bernardes LSC, Zani CL, Carvalho I (2013) Trypanosomatidae diseases: from the current therapy to the efficacious role of trypanothione reductase in drug discovery. Curr Med Chem 20:2673–2696CrossRef
30.
go back to reference Fonseca-Berzal C, Palmeiro-Roldán R, Escario JA, Torrado S, Arán VJ, Torrado-Santiago S, Gómez-Barrio A (2015) Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system. Exp Parasitol 149:84–91CrossRef Fonseca-Berzal C, Palmeiro-Roldán R, Escario JA, Torrado S, Arán VJ, Torrado-Santiago S, Gómez-Barrio A (2015) Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system. Exp Parasitol 149:84–91CrossRef
31.
go back to reference Streck L, Sarmento VHV, Machado PRL, Farias KJS, Fernandes-Pedrosa MF, Silva-Júnior AA (2016) Phase transitions of isotropic to anisotropic biocompatible lipid-based drug delivery systems overcoming insoluble benznidazole loading. Int J Mol Sci 17:981–998CrossRef Streck L, Sarmento VHV, Machado PRL, Farias KJS, Fernandes-Pedrosa MF, Silva-Júnior AA (2016) Phase transitions of isotropic to anisotropic biocompatible lipid-based drug delivery systems overcoming insoluble benznidazole loading. Int J Mol Sci 17:981–998CrossRef
32.
go back to reference Leonardi D, Bombardiere ME, Salomon CJ (2013) Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats. Int J Biol Macromol 62:543–548CrossRef Leonardi D, Bombardiere ME, Salomon CJ (2013) Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats. Int J Biol Macromol 62:543–548CrossRef
33.
go back to reference Soares-Sobrinho JL, Santos FLA, Lyra MAM, Alves LDS, Rolim LA, Lima AAN, Nunes LCC, Soares MFR, Rolim-Neto PJ, Torres-Labandeira JJ (2012) Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers. Carbohyd Polym 89:323–330CrossRef Soares-Sobrinho JL, Santos FLA, Lyra MAM, Alves LDS, Rolim LA, Lima AAN, Nunes LCC, Soares MFR, Rolim-Neto PJ, Torres-Labandeira JJ (2012) Benznidazole drug delivery by binary and multicomponent inclusion complexes using cyclodextrins and polymers. Carbohyd Polym 89:323–330CrossRef
34.
go back to reference Melo PN, Barbosa EG, Caland LB, Carpegianni H, Garnero C, Longhi M, Fernandes-Pedrosa MF, Silva-Júnior AA (2013) Host-guest interactions between benznidazole and beta-cyclodextrin in multicomponent complex systems involving hydrophilic polymers and triethanolamine in aqueous solution. J Mol Liq 186:147–156CrossRef Melo PN, Barbosa EG, Caland LB, Carpegianni H, Garnero C, Longhi M, Fernandes-Pedrosa MF, Silva-Júnior AA (2013) Host-guest interactions between benznidazole and beta-cyclodextrin in multicomponent complex systems involving hydrophilic polymers and triethanolamine in aqueous solution. J Mol Liq 186:147–156CrossRef
35.
go back to reference Melo PN, Barbosa EG, Garnero C, Caland LB, Fernandes-Pedrosa MF, Longhi MR, Silva-Júnior AA (2016) Interaction pathways of specific co-solvents with hydroxypropyl-β-cyclodextrin inclusion complexes with benznidazole in liquid and solid phase. J Mol Liq 223:350–359CrossRef Melo PN, Barbosa EG, Garnero C, Caland LB, Fernandes-Pedrosa MF, Longhi MR, Silva-Júnior AA (2016) Interaction pathways of specific co-solvents with hydroxypropyl-β-cyclodextrin inclusion complexes with benznidazole in liquid and solid phase. J Mol Liq 223:350–359CrossRef
36.
go back to reference U.S. FDA. Dissolution testing of immediate release solid oral dosage forms, guidance for industry, Food and Drug Administration. Center Drug Evaluation and Research. (CDER) (1997) Rockville, USA, pp 1–10 U.S. FDA. Dissolution testing of immediate release solid oral dosage forms, guidance for industry, Food and Drug Administration. Center Drug Evaluation and Research. (CDER) (1997) Rockville, USA, pp 1–10
37.
go back to reference USP 30-NF 25. 30th revision of the United States Pharmacopeia and 25th edition of National Formulary (2007) United States Pharmacopeial Convention. Rockville, USA USP 30-NF 25. 30th revision of the United States Pharmacopeia and 25th edition of National Formulary (2007) United States Pharmacopeial Convention. Rockville, USA
38.
go back to reference Saini GSS, Kaur S, Tripathi SK, Dogra SD, Abbas JM, Mahajan CG (2011) Vibrational spectroscopic and density functional theory studies of chloranil–imidazole interaction. Vib Spectrosc 56:66–73CrossRef Saini GSS, Kaur S, Tripathi SK, Dogra SD, Abbas JM, Mahajan CG (2011) Vibrational spectroscopic and density functional theory studies of chloranil–imidazole interaction. Vib Spectrosc 56:66–73CrossRef
39.
go back to reference Mohan PRK, Sreelakshmi G, Muraleedharan CV, Joseph R (2012) Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vib Spectrosc 62:77–84CrossRef Mohan PRK, Sreelakshmi G, Muraleedharan CV, Joseph R (2012) Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vib Spectrosc 62:77–84CrossRef
40.
go back to reference D’Sa DJ, Lechuga-Ballesteros D, Chan HK (2015) Isothermal microcalorimetry of pressurized systems II: effect of excipient and water ingress on formulation stability of amorphous glycopyrrolate. Pharm Res 32:714–722CrossRef D’Sa DJ, Lechuga-Ballesteros D, Chan HK (2015) Isothermal microcalorimetry of pressurized systems II: effect of excipient and water ingress on formulation stability of amorphous glycopyrrolate. Pharm Res 32:714–722CrossRef
41.
go back to reference Zhang D, Zhang J, Jiang K, Li K, Cong Y, Pu S, Jin Y, Lin J (2016) Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin. Spectrochim Acta A 152:501–508CrossRef Zhang D, Zhang J, Jiang K, Li K, Cong Y, Pu S, Jin Y, Lin J (2016) Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin. Spectrochim Acta A 152:501–508CrossRef
42.
go back to reference Oliveira AR, Molina EF, Mesquita PC, Fonseca JLC, Rossanezi G, Fernandes-Pedrosa MF, Oliveira AG, Silva-Júnior AA (2013) Structural and thermal properties of spray-dried methotrexate-loaded biodegradable microparticles. J Therm Anal Calorim 112:555–565CrossRef Oliveira AR, Molina EF, Mesquita PC, Fonseca JLC, Rossanezi G, Fernandes-Pedrosa MF, Oliveira AG, Silva-Júnior AA (2013) Structural and thermal properties of spray-dried methotrexate-loaded biodegradable microparticles. J Therm Anal Calorim 112:555–565CrossRef
43.
go back to reference Aigner Z, Berkesi O, Farkas G, Szabó-Révész P (2012) Dsc, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J Pharmaceut Biomed 57:62–67CrossRef Aigner Z, Berkesi O, Farkas G, Szabó-Révész P (2012) Dsc, X-ray and FTIR studies of a gemfibrozil/dimethyl-β-cyclodextrin inclusion complex produced by co-grinding. J Pharmaceut Biomed 57:62–67CrossRef
44.
go back to reference Dandawate PR, Vyas A, Ahmad A, Banerjee S, Deshpande J, Swamy KV, Jamadar A, Dumhe-Klaire AC, Padhye S, Sarkar FH (2012) Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic. Cancer Pharm 29:1775–1786 Dandawate PR, Vyas A, Ahmad A, Banerjee S, Deshpande J, Swamy KV, Jamadar A, Dumhe-Klaire AC, Padhye S, Sarkar FH (2012) Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic. Cancer Pharm 29:1775–1786
45.
go back to reference Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB (2007) Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm 67:531–539CrossRef Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJB (2007) Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified β-cyclodextrin. Eur J Pharm Biopharm 67:531–539CrossRef
46.
go back to reference Naidu NB, Chowdary KPR, Murthy KVR, Satyanarayana KVR, Hayman AR, Becket G (2004) Physicochemical characterization and dissolution properties of meloxicam–cyclodextrin binary systems. J Pharmaceut Biomed 35:75–86CrossRef Naidu NB, Chowdary KPR, Murthy KVR, Satyanarayana KVR, Hayman AR, Becket G (2004) Physicochemical characterization and dissolution properties of meloxicam–cyclodextrin binary systems. J Pharmaceut Biomed 35:75–86CrossRef
47.
go back to reference Maria DN, Abd-Elgawad AEH, Soliman OAE, El-dahan MS, Jablonski MM (2017) Nimodipine ophthalmic formulations for management of glaucoma. Pharm Res 34:809–824CrossRef Maria DN, Abd-Elgawad AEH, Soliman OAE, El-dahan MS, Jablonski MM (2017) Nimodipine ophthalmic formulations for management of glaucoma. Pharm Res 34:809–824CrossRef
48.
go back to reference Wang L, Yan J, Li Y, Xu K, Li S, Tang P, Li H (2016) The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin. J Pharmaceut Biomed 117:453–463CrossRef Wang L, Yan J, Li Y, Xu K, Li S, Tang P, Li H (2016) The influence of hydroxypropyl-β-cyclodextrin on the solubility, dissolution, cytotoxicity, and binding of riluzole with human serum albumin. J Pharmaceut Biomed 117:453–463CrossRef
49.
go back to reference Cho AR, Chun YG, Kim BK, Park DJ (2014) Preparation of alginate–CaCl2 microspheres as resveratrol carriers. J Mater Sci 49:4612–4619CrossRef Cho AR, Chun YG, Kim BK, Park DJ (2014) Preparation of alginate–CaCl2 microspheres as resveratrol carriers. J Mater Sci 49:4612–4619CrossRef
50.
go back to reference Cho W, Kim MS, Jung MS, Park J, Cha KH, Kim JS, Park HJ, Alhalaweh A, Velaga SP, Hwang SJ (2015) Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes. Int J Pharm 478:288–296CrossRef Cho W, Kim MS, Jung MS, Park J, Cha KH, Kim JS, Park HJ, Alhalaweh A, Velaga SP, Hwang SJ (2015) Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes. Int J Pharm 478:288–296CrossRef
51.
go back to reference Mesquita PC, Oliveira AR, Pedrosa MFF, Oliveira AG, Silva-Júnior AA (2015) Physicochemical aspects involved in methotrexate release kinetics from biodegradable spray-dried chitosan microparticles. J Phys Chem Solids 81:27–33CrossRef Mesquita PC, Oliveira AR, Pedrosa MFF, Oliveira AG, Silva-Júnior AA (2015) Physicochemical aspects involved in methotrexate release kinetics from biodegradable spray-dried chitosan microparticles. J Phys Chem Solids 81:27–33CrossRef
52.
go back to reference Kadota K, Nishimura T, Hotta D, Tozuka Y (2015) Preparation of composite particles of hydrophilic or hydrophobic drugs with highly branched cyclic dextrin via spray drying for dry powder inhalers. Powder Technol 283:16–23CrossRef Kadota K, Nishimura T, Hotta D, Tozuka Y (2015) Preparation of composite particles of hydrophilic or hydrophobic drugs with highly branched cyclic dextrin via spray drying for dry powder inhalers. Powder Technol 283:16–23CrossRef
53.
go back to reference Loftsson T, Duchêne D (2007) Cyclodextrins and their pharmaceutical applications. Int J Pharm 329:1–11CrossRef Loftsson T, Duchêne D (2007) Cyclodextrins and their pharmaceutical applications. Int J Pharm 329:1–11CrossRef
54.
go back to reference Naito Y, Matsuda H, Shimomura K, Kurihara K, Tochigi K, Tomono K (2013) Measurement and correlation of solubilities of the poorly water-soluble pharmaceutical compound etodolac by addition of co-solvents. Fluid Phase Equilib 357:43–49CrossRef Naito Y, Matsuda H, Shimomura K, Kurihara K, Tochigi K, Tomono K (2013) Measurement and correlation of solubilities of the poorly water-soluble pharmaceutical compound etodolac by addition of co-solvents. Fluid Phase Equilib 357:43–49CrossRef
55.
go back to reference Brewster ME, Loftsson T (2007) Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliver Rev 59:645–666CrossRef Brewster ME, Loftsson T (2007) Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliver Rev 59:645–666CrossRef
56.
go back to reference Mura P, Bettinetti GP, Manderioli A, Faucci MT, Bramanti G, Sorrenti M (1998) Interactions of ketoprofen and ibuprofen with b-cyclodextrins in solution and in the solid state. Int J Pharm 166:189–203CrossRef Mura P, Bettinetti GP, Manderioli A, Faucci MT, Bramanti G, Sorrenti M (1998) Interactions of ketoprofen and ibuprofen with b-cyclodextrins in solution and in the solid state. Int J Pharm 166:189–203CrossRef
57.
go back to reference Miletic T, Kyriakos K, Graovac A, Ibric S (2013) Spray-dried voriconazole–cyclodextrin complexes: solubility, dissolution rate and chemical stability. Carbohyd Polym 98:122–130CrossRef Miletic T, Kyriakos K, Graovac A, Ibric S (2013) Spray-dried voriconazole–cyclodextrin complexes: solubility, dissolution rate and chemical stability. Carbohyd Polym 98:122–130CrossRef
Metadata
Title
Designing and monitoring microstructural properties of oligosaccharide/co-solvent ternary complex particles to improve benznidazole dissolution
Authors
Polyanne N. de Melo
Lilia B. de Caland
Matheus F. Fernandes-Pedrosa
Arnóbio Antônio da Silva-Júnior
Publication date
31-10-2017
Publisher
Springer US
Published in
Journal of Materials Science / Issue 4/2018
Print ISSN: 0022-2461
Electronic ISSN: 1573-4803
DOI
https://doi.org/10.1007/s10853-017-1720-3

Other articles of this Issue 4/2018

Journal of Materials Science 4/2018 Go to the issue

Premium Partners